Canada-based medical marijuana company Tilray has raised $153 million (over ₹1,050 crore) in its Initial Public Offering (IPO) at US' stock market Nasdaq. Founded in 2013, Tilray sells its products to patients, researchers, pharmacies and even governments. Earlier this year, Canadian firms Cronos Group and Canopy Growth became first marijuana producers to be listed on Nasdaq and NYSE respectively.